@article{oai:kumadai.repo.nii.ac.jp:00028048,
 author = {増田, 稔郎 and 別府, 透 and 水元, 孝郎 and 石河, 隆敏 and 近本, 亮 and 林, 洋光 and Hayashi, Hiromitsu and 岡部, 弘尚 and 太田尾, 龍 and 哈, 斯塔 and Takamori, Hiroshi and 高森, 啓史 and 馬場, 秀夫 and 増田, 稔郎 and Masuda, Toshiro and Beppu, Toru and Mizumoto, Takao and Ishiko, Takatoshi and Chikamoto, Akira and 林, 洋光 and Hayashi, Hiromitsu and Okabe, Hirohisa and Otao, Ryu and Hasita, Horlad and Takamori, Hiroshi and Baba, Hideo},
 issue = {115},
 journal = {Hepato-Gastroenterology},
 month = {May},
 note = {application/pdf, application/pdf, application/pdf, 論文(Article), Background/Aims: To investigate the efficacy and the safety of a hybrid
ablation combining a percutaneous and endoscopic approach for multinodular
hepatocellular carcinomas.
Methodology: Hybrid ablation consists of a percutaneous approach for
deep-sited tumors and an endoscopic approach for superficial ones. Between
January 1991 and December 2007, fourty-eight patients with 139 nodules
were treated with the hybrid ablation. The perioperative clinical data and
prognosis of the hybrid approach group were compared with 15 patients with
superficial and deep-sited multinodular HCCs treated by the pure endoscopic
ablation.
Results: With regard to the deep-site of the liver tumors, the complete
disappearance of tumor enhancement was observed in 76 of 77 tumors
(98.7%) in the hybrid ablation group, and 15 of 18 tumors (83.3%) in the pure
endoscopic ablation group (p = 0.02). The mean operation time (236.5
minutes), the mean amount of intraoperative bleeding (20.3g), the median
days of postoperative hospital stay (14 days), major complication rates
(10.4%), and the 5-year overall survival (42%) in the hybrid ablation group
were similar to the pure endoscopic group.
Conclusions: Hybrid ablation is a clinically useful treatment for multinodular
hepatocellular carcinomas located in both superficial and deep-site of the liver},
 pages = {836--839},
 title = {Hybrid Ablation using Percutaneous and Edoscopic Approach for Multi-Nodular Hepatocellular Carcinomas},
 volume = {59},
 year = {2012},
 yomi = {ハヤシ, ヒロミツ and タカモリ, ヒロシ and マスダ, トシロウ and ハヤシ, ヒロミツ}
}